ResMed Net Income increased by 1.6% to $398.73M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $365.04M to $398.73M. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 31.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $195.10M | $203.61M | $201.75M | $179.01M | $195.06M | $210.48M | $224.91M | $232.50M | $229.66M | $219.42M | $208.80M | $300.49M | $292.24M | $311.36M | $344.62M | $365.04M | $379.71M | $348.54M | $392.59M | $398.73M |
| QoQ Change | — | +4.4% | -0.9% | -11.3% | +9.0% | +7.9% | +6.9% | +3.4% | -1.2% | -4.5% | -4.8% | +43.9% | -2.7% | +6.5% | +10.7% | +5.9% | +4.0% | -8.2% | +12.6% | +1.6% |
| YoY Change | — | — | — | — | -0.0% | +3.4% | +11.5% | +29.9% | +17.7% | +4.2% | -7.2% | +29.2% | +27.2% | +41.9% | +65.0% | +21.5% | +29.9% | +11.9% | +13.9% | +9.2% |